Hints and tips:
Related Special Reports
...Smiths announced in late March that Paul Keel, an American, would leave the company immediately after less than three years in charge....
...company’s biggest-selling drugs....
...Companies: Frozen potato processor Lamb Weston and consumer packaged foods company Conagra Brands will report earnings results before the bell....
...Huge demand for GLP-1s, the lucrative new class of diabetes and weight-loss drugs that include Wegovy and Zepbound, is testing the capacity of plants capable of producing and administering the drug. 4....
...AstraZeneca beat analysts’ estimates with 18 per cent growth in revenue in the first quarter of 2024, driven by stronger sales of its cancer drugs....
...Elon Musk’s pioneering electric car company faces slowing demand and a brutal price war. Shareholders also want to know about a plan to move company headquarters from Delaware to Texas....
...The US biotech company reported first-quarter earnings of $3.67 a share, beating analysts’ consensus estimates of $3.44. That pushed Biogen’s shares up 4.3 per cent in early trading on Wednesday....
...Since launching a war on drug traffickers driving a wave of violence across the once-peaceful Andean nation, the president’s popularity has surged despite growing concerns over a slide towards authoritarianism...
...Companies: Verizon is expected to show strong subscriber growth, driven by 5G adoption, when it releases first-quarter results....
...Bobby Gaspar, co-founder and chief executive of Orchard, said Lenmeldy was “a paradigm-shifting medicine”, adding that the company was “committed to enabling broad, expedient and sustainable access to this...
...Chief executive Elon Musk said the company would provide more details in August, alongside a “robotaxis” announcement....
...So you’ve had companies report good progress developing drugs. And then also a couple of like big acquisitions by big pharma groups....
...Here’s what the trend means for companies around the world....
...In March, the boss of Admiral said the sector was in a “different situation” and that the FTSE 100 company had even put through a “small price decrease” recently to win business....
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...The company’s work to date has involved analysing thousands of donated human livers to develop an understanding of the causes of disease, and studying whether making changes to RNA — a vital molecule for...
...The company has genetically validated two other drug targets....
...Investors like to hear a bullish story from companies, too....
...The hedge fund has stayed clear of bonds at Thames Water’s holding company Kemble, however, which sit outside the regulatory ringfence and are trading at less than 15 pence....
Eiopa head says rise in losses from natural catastrophes needs to be addressed by firms and member states
...His plans for a second term included populist measures such as higher taxes on big companies and the wealthy, a commitment to drive down house prices and cut the cost of drugs, as well as a promise to restore...
...And in recent years, the securitisation market has become a welcoming home to deals backed by everything from music rights to software companies’ private credit loans....
...US-based International Paper has agreed to buy UK rival DS Smith in a deal valued at £7.8bn, the companies said on Tuesday....
...to a default on the holding company’s bonds....
International Edition